EUVIMEDEUVIMED entdecken
Crossref

A Comparative Study Between Intravenous Esmolol and Intravenous Labetalol for Attenuation of Haemodynamic Response During Laryngoscopy and Tracheal Intubation

Vikash Gaurav

International Journal of Pharmaceutical Quality Assurance · 09.07.2026 · 16 (10)

DOI: 10.25258/ijpqa.16.10.81 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 09.07.2026. Verfasst von Vikash Gaurav.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: “ Laryngoscopy and tracheal intubation trigger sympathetic responses, causing transient elevations in heart rate and blood pressure, which may be hazardous in patients with cardiovascular risk. Beta-blockers such as esmolol and labetalol are commonly used to attenuate these hemodynamic responses.

Aim

To compare the efficacy of intravenous esmolol and labetalol in blunting the hemodynamic response during laryngoscopy and tracheal intubation in adult patients undergoing elective surgery. Methodology: A prospective, hospital-based, comparative observational study was conducted on 90 ASA I–II adult patients, randomized to receive esmolol (0.5 mg/kg, n=45) or labetalol (0.25 mg/kg, n=45) before intubation. Hemodynamic parameters—heart rate, diastolic blood pressure, and rate pressure product—were recorded at baseline, post-induction, intubation, and at 1, 3-, 5-, 10-, and 15-minutes post-intubation.

Results

Baseline parameters were comparable between groups. Labetalol produced significantly lower heart rates, diastolic pressures, and rate pressure product than esmolol at most time points, indicating superior attenuation of cardiovascular stress. A transient 3–5-minute window showed comparable efficacy.

Conclusion

Intravenous labetalol (0.25 mg/kg) provides more sustained hemodynamic stability than esmolol (0.5 mg/kg) during laryngoscopy and intubation, making it the preferred agent for peri-intubation cardiovascular protection

Zitieren

APA

Gaurav, V. (2026). A Comparative Study Between Intravenous Esmolol and Intravenous Labetalol for Attenuation of Haemodynamic Response During Laryngoscopy and Tracheal Intubation. International Journal of Pharmaceutical Quality Assurance, 16(10). https://doi.org/10.25258/ijpqa.16.10.81

Vancouver

Gaurav V. A Comparative Study Between Intravenous Esmolol and Intravenous Labetalol for Attenuation of Haemodynamic Response During Laryngoscopy and Tracheal Intubation. International Journal of Pharmaceutical Quality Assurance. 2026;16(10). doi:10.25258/ijpqa.16.10.81

BibTeX
@article{Gaurav2026,
  author = {Gaurav, Vikash},
  title = {A Comparative Study Between Intravenous Esmolol and Intravenous Labetalol for Attenuation of Haemodynamic Response During Laryngoscopy and Tracheal Intubation},
  journal = {International Journal of Pharmaceutical Quality Assurance},
  year = {2026},
  volume = {16},
  number = {10},
  doi = {10.25258/ijpqa.16.10.81}
}
Kostenlos starten →